264 related articles for article (PubMed ID: 30659922)
1. Comparison of fused-filament fabrication to direct compression and injection molding in the manufacture of oral tablets.
Fuenmayor E; Forde M; Healy AV; Devine DM; Lyons JG; McConville C; Major I
Int J Pharm; 2019 Mar; 558():328-340. PubMed ID: 30659922
[TBL] [Abstract][Full Text] [Related]
2. Mass-customization of oral tablets via the combination of 3D printing and injection molding.
Fuenmayor E; O'Donnell C; Gately N; Doran P; Devine DM; Lyons JG; McConville C; Major I
Int J Pharm; 2019 Oct; 569():118611. PubMed ID: 31415874
[TBL] [Abstract][Full Text] [Related]
3. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
4. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
5. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
6. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
[TBL] [Abstract][Full Text] [Related]
7. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Verstraete G; Van Renterghem J; Van Bockstal PJ; Kasmi S; De Geest BG; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):214-21. PubMed ID: 27113866
[TBL] [Abstract][Full Text] [Related]
8. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
[TBL] [Abstract][Full Text] [Related]
9. Tablet coating by injection molding technology - Optimization of coating formulation attributes and coating process parameters.
Desai PM; Puri V; Brancazio D; Halkude BS; Hartman JE; Wahane AV; Martinez AR; Jensen KD; Harinath E; Braatz RD; Chun JH; Trout BL
Eur J Pharm Biopharm; 2018 Jan; 122():25-36. PubMed ID: 29024728
[TBL] [Abstract][Full Text] [Related]
10. A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices.
Verstraete G; Mertens P; Grymonpré W; Van Bockstal PJ; De Beer T; Boone MN; Van Hoorebeke L; Remon JP; Vervaet C
Int J Pharm; 2016 Nov; 513(1-2):602-611. PubMed ID: 27686052
[TBL] [Abstract][Full Text] [Related]
11. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Claeys B; Vervaeck A; Hillewaere XK; Possemiers S; Hansen L; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Feb; 90():44-52. PubMed ID: 25448075
[TBL] [Abstract][Full Text] [Related]
12. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release.
Yang Y; Wang H; Li H; Ou Z; Yang G
Eur J Pharm Sci; 2018 Mar; 115():11-18. PubMed ID: 29305984
[TBL] [Abstract][Full Text] [Related]
13. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.
Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW
Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
15. Development of Maltodextrin-Based Immediate-Release Tablets Using an Integrated Twin-Screw Hot-Melt Extrusion and Injection-Molding Continuous Manufacturing Process.
Puri V; Brancazio D; Desai PM; Jensen KD; Chun JH; Myerson AS; Trout BL
J Pharm Sci; 2017 Nov; 106(11):3328-3336. PubMed ID: 28684263
[TBL] [Abstract][Full Text] [Related]
16. Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry.
Khaled SA; Alexander MR; Irvine DJ; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
AAPS PharmSciTech; 2018 Nov; 19(8):3403-3413. PubMed ID: 30097806
[TBL] [Abstract][Full Text] [Related]
17. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
18. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
19. Screening of pharmaceutical polymers for extrusion-Based Additive Manufacturing of patient-tailored tablets.
Samaro A; Janssens P; Vanhoorne V; Van Renterghem J; Eeckhout M; Cardon L; De Beer T; Vervaet C
Int J Pharm; 2020 Aug; 586():119591. PubMed ID: 32640268
[TBL] [Abstract][Full Text] [Related]
20. Tailoring drug release in bilayer tablets through droplet deposition modeling and injection molding.
Ebrahimi F; Xu H; Fuenmayor E; Major I
Int J Pharm; 2024 Mar; 653():123859. PubMed ID: 38307401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
